Loading stock data...

Shree Ganesh Remedies Limited

BSE: SGRL

BSE
556.90 -5.20 (-0.93%)

Prev Close

562.1

Open Price

561.25

Volume

2,748

Today Low / High

546.5 / 567.9

52 WK Low / High

500 / 950

Range

529 - 585

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 556.9, reflecting a change of -5.2 (-0.9251%). The expected target range on the BSE is 529 - 585. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

09 Sep 589.05 -1.86%
08 Sep 572.60 2.57%
05 Sep 599.90 -4.78%
04 Sep 593.75 -0.46%
03 Sep 581.50 2.05%
02 Sep 580.50 2.02%
01 Sep 600.00 -1.72%
29 Aug 594.05 -1.16%
28 Aug 597.80 -1.55%
26 Aug 585.00 -0.72%
25 Aug 592.75 -0.30%
22 Aug 628.00 -5.61%
21 Aug 581.05 5.59%
20 Aug 575.55 -0.23%
19 Aug 609.00 -4.54%

Shree Ganesh Remedies Limited Graph

Shree Ganesh Remedies Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Shree Ganesh Remedies Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 556.90, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 556.90 562.47 506.22 - 618.72
568.04 454.43 - 681.65
573.61 401.52 - 745.69
Bearish Scenario 556.90 551.33 496.20 - 606.46
545.76 436.61 - 654.91
540.19 378.14 - 702.25

Overview of Shree Ganesh Remedies Limited

ISIN

INE414Y01015

Industry

Medical - Pharmaceuticals

Vol.Avg

7,446

Market Cap

7,419,855,690

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

1,103.46

DCF

-525

Financial Ratios Every Investor Needs

Stock Dividend of SGRL

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2023-09-07 September 07, 23 0.5 0.5 2023-09-07 2023-09-25
2022-09-15 September 15, 22 0.49646 0.49646 2022-09-16 2022-10-28
2021-09-08 September 08, 21 1.44799 1.7376 2021-09-11 2021-10-18
2020-09-01 September 01, 20 1.11274 1.4894 2020-09-02 2020-10-19
2019-08-22 August 22, 19 0.92729 1.2411 2019-08-23 2019-09-30

Stock Rating Details for SGRL

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 108.60 Cr 35.87 Cr 72.72 Cr 0.6697 0.00 Cr 0.00 Cr 62.60 Cr 23.07 Cr 17.96 39.21 Cr 0.2124
2024-03-31 125.90 Cr 58.48 Cr 67.42 Cr 0.5355 0.02 Cr 0.94 Cr 57.25 Cr 28.11 Cr 22.34 44.88 Cr 0.2233
2023-03-31 90.22 Cr 47.16 Cr 43.06 Cr 0.4772 2.08 Cr 0.66 Cr 20.59 Cr 17.02 Cr 13.86 26.49 Cr 0.1887
2022-03-31 71.29 Cr 37.05 Cr 34.24 Cr 0.4802 1.98 Cr 0.55 Cr 15.33 Cr 13.40 Cr 11.08 18.47 Cr 0.1880
2021-03-31 49.08 Cr 22.02 Cr 27.06 Cr 0.5514 0.76 Cr 0.47 Cr 11.45 Cr 9.75 Cr 8.07 15.80 Cr 0.1987

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 10.03 Cr 191.94 Cr 46.79 Cr 145.1552 Cr 38.38 Cr 28.35 Cr 22.02 Cr 103.31 Cr 0.00 Cr 0.00 Cr 0.08 Cr 16.1824 Cr
2024-03-31 15.85 Cr 170.94 Cr 48.84 Cr 122.0983 Cr 36.45 Cr 20.60 Cr 24.99 Cr 99.11 Cr 0.00 Cr 0.00 Cr 0.09 Cr 18.6808 Cr
2023-03-31 8.65 Cr 143.83 Cr 54.90 Cr 88.9372 Cr 33.51 Cr 24.86 Cr 18.18 Cr 76.45 Cr 5.85 Cr 0.00 Cr 0.50 Cr 23.7400 Cr
2022-03-31 3.88 Cr 77.02 Cr 15.44 Cr 61.5739 Cr 0.00 Cr -3.88 Cr 13.64 Cr 29.82 Cr 0.00 Cr 0.00 Cr 1.16 Cr 15.0397 Cr
2021-03-31 3.47 Cr 60.60 Cr 10.59 Cr 50.0032 Cr 0.21 Cr -3.25 Cr 12.71 Cr 20.29 Cr 3.72 Cr 0.00 Cr 1.61 Cr 10.1878 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 30.6640 Cr -35.6581 Cr -1.0883 Cr 7.4689 Cr -5.9070 Cr 9.9465 Cr -23.1951 Cr 23.0684 Cr 0.9623 Cr 0.0000 Cr 2.9702 Cr
2024-03-31 30.4483 Cr -33.0091 Cr 9.8408 Cr -0.6897 Cr 7.2033 Cr 15.8535 Cr -31.1380 Cr 28.1080 Cr 3.6952 Cr -0.6256 Cr -6.8122 Cr
2023-03-31 17.0114 Cr -53.5748 Cr 41.3305 Cr -34.5718 Cr 4.7670 Cr 8.6502 Cr -51.5832 Cr 22.5843 Cr 30.9324 Cr -0.6003 Cr -4.5347 Cr
2022-03-31 13.4167 Cr -11.9131 Cr -1.0867 Cr -1.9110 Cr 0.4169 Cr 3.8832 Cr -15.3277 Cr 18.0052 Cr 0.5221 Cr -1.6088 Cr -0.9278 Cr
2021-03-31 3.3115 Cr -0.9422 Cr -0.6569 Cr 3.3025 Cr 1.7124 Cr 3.4663 Cr -0.0090 Cr 12.9495 Cr -0.4979 Cr 0.0000 Cr -7.2093 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 24.67 Cr 8.73 Cr 15.94 Cr 0.6462 4.88 Cr 3.45 Cr 2.68 7.96 Cr 0.1397
2025-03-31 24.43 Cr 5.84 Cr 18.59 Cr 0.7608 15.90 Cr 6.59 Cr 5.13 9.84 Cr 0.2697
2024-12-31 27.05 Cr 8.40 Cr 18.65 Cr 0.6896 7.20 Cr 5.42 Cr 4.22 10.61 Cr 0.2005
2024-09-30 32.33 Cr 18.08 Cr 14.25 Cr 0.4408 8.89 Cr 6.41 Cr 4.97 11.50 Cr 0.1981
2024-06-30 24.78 Cr 12.76 Cr 12.02 Cr 0.4850 6.11 Cr 4.65 Cr 3.62 8.12 Cr 0.1876

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 10.03 Cr 18.26 Cr 28.29 Cr 22.27 Cr 22.02 Cr 77.58 Cr 103.31 Cr 191.94 Cr 46.79 Cr
2024-12-31 0.00 Cr 0.00 Cr 21.27 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -133.14 Cr
2024-09-30 14.65 Cr 6.55 Cr 21.29 Cr 31.78 Cr 17.86 Cr 73.30 Cr 99.40 Cr 178.30 Cr 45.17 Cr
2024-06-30 0.00 Cr 0.00 Cr 20.92 Cr 0.00 Cr 0.00 Cr 20.92 Cr 0.00 Cr 0.00 Cr -122.10 Cr
2024-03-31 16.26 Cr 4.66 Cr 20.92 Cr 20.34 Cr 24.99 Cr 70.20 Cr 97.11 Cr 170.94 Cr 48.84 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 6.59 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 5.42 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 6.41 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 4.65 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 11.99 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2021-11-01 November 01, 21 6:5
2020-10-06 October 06, 20 29:26

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹843.40 ₹100,991,834,050.00 ₹68,509.00

Key Executives

Whole Time Director & Chief Financial Officer
Mr. Parth Chandulal Kothia

Gender: male

Year Born: 1996

Chairman & MD
Mr. Chandulal Manubhai Kothia

Gender: male

Year Born: 1963

Compliance Officer & Company Secretary
Mr. Aditya Vikrambhai Patel

Gender: male

Year Born: 1993

Whole Time Director
Mr. Gunjan Chandulal Kothia

Gender: male

Year Born: 1992

FAQs about Shree Ganesh Remedies Limited

Who is the CEO of the company?

The CEO is Chandulal Manubhai Kothia.

What is the current market price of the stock?

The current price is ₹578.10.

What is the 52-week price range?

The range is ₹500-950.

What is the market capitalization of the company?

The market capitalization is ₹741.99 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 33.99.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Shree Ganesh Remedies Limited (ISIN: INE414Y01015) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹741.99 crores and an average daily volume of 7,446 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.